Cargando…
Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome
Smith-Lemli-Opitz Syndrome (SLOS) is a recessive human disease caused by defective cholesterol (CHOL) synthesis at the level of DHCR7 (7-dehydrocholesterol reductase), which normally catalyzes the conversion of 7-dehydrocholesterol (7DHC) to CHOL. Formation and abnormal accumulation of 7DHC and 7DHC...
Autores principales: | Fliesler, Steven J., Peachey, Neal S., Herron, Josi, Hines, Kelly M., Weinstock, Nadav I., Ramachandra Rao, Sriganesh, Xu, Libin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775248/ https://www.ncbi.nlm.nih.gov/pubmed/29352199 http://dx.doi.org/10.1038/s41598-018-19592-8 |
Ejemplares similares
-
Author Correction: Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome
por: Fliesler, Steven J., et al.
Publicado: (2018) -
Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention
por: Fliesler, Steven J., et al.
Publicado: (2018) -
7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome
por: Tomita, Hideaki, et al.
Publicado: (2022) -
Generation and validation of a conditional knockout mouse model for the study of the Smith-Lemli-Opitz syndrome
por: Kanuri, Babunageswararao, et al.
Publicado: (2020) -
Morphological, biochemical, and transcriptomic characterization of iPSC-derived human RPE cells from normal and Smith-Lemli-Opitz syndrome patients
por: Farkas, Michael H., et al.
Publicado: (2022)